Skip to main content

Exela Named Leader in Everest Group’s Intelligent Automation in Healthcare – Solutions PEAK Matrix® Assessment 2022

Written by Customer Service on . Posted in Public Companies.

Everest Group’s Intelligent Automation in Healthcare – Solutions PEAK Matrix® Assessment 2022

Everest Group’s Intelligent Automation in Healthcare – Solutions PEAK Matrix® Assessment 2022

Everest Group’s Intelligent Automation in Healthcare – Solutions PEAK Matrix® Assessment 2022

IRVING, Texas, Nov. 19, 2021 (GLOBE NEWSWIRE) — Exela Technologies, Inc. (“Exela”) (NASDAQ: XELA), a leading provider of Business Process Automation solutions, today announced that it has been recognized as a ‘Leader’ in the first edition of Everest Group’s Intelligent Automation in Healthcare – Solutions PEAK Matrix® Assessment 2022. This report provides a detailed analysis and assessment of 18 operations service providers featured on the Intelligent Automation in Healthcare – Solutions PEAK Matrix®. The assessment considers providers’ positioning in terms of market impact as well as their vision and capability.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/a82e780c-1df0-4eac-ab7f-c5ac1a43e4ee

“The COVID-19 pandemic accentuated healthcare payers and providers need to invest in solutions that can help them reduce business continuity risks while improving operational efficiency. In particular, intelligent automation emerged as a high priority area for these buyers,” said Ankur Verma, Practice Director, Everest Group. “Exela Technologies, with its automation-led approach, emerged as highly suited to address buyers’ needs. Its home-grown automation expertise and a diversified client base across the size spectrum, empowers it with a holistic understanding of client needs and adequate customization, placing it as one of the Leaders on the Intelligent Automation in Healthcare – Solutions PEAK Matrix® Assessment 2022.”

Exela was recognized as one of the few providers who have developed most of their healthcare automation solutions in-house, providing them the ability to customize solutions based on client needs efficiently, while reducing operational costs.

“Infusion of Intelligent Automation in Healthcare has reduced fragmentation of providers, provided interoperability between proprietary applications and allowed data mobility across the Healthcare ecosystem,” said Srini Murali, Exela’s President, Americas, & APAC. “We are thankful to our customers, some of the most innovative healthcare institutions globally, who gave us the opportunity to deploy strategic and innovative initiatives, while leveraging our deep knowledge of the healthcare industry. This has enabled us to be recognized as a Leader in the inaugural edition of the report. We look forward to our continued contribution to the betterment of the industry.”

Exela’s Healthcare Intelligent Automation portfolio provides a seamless digital journey in the process-heavy Healthcare industry. Healthcare is plagued with hundreds of repetitive, manual tasks, which account for over $1 trillion in administrative costs per year or close to 35% of the overall cost. Exela’s Intelligent Automation uses a mix of proprietary RPA and AI/ML technology to provide highly scalable and adaptable processes strategies to significantly reduce costs.    

Everest Group is an industry-leading research firm focused on strategic IT, business process services, and engineering. The ‘Leaders’ in Everest Group’s PEAK Matrix assessments are those companies that demonstrate exceptional innovation and transition management in their engagements while enhancing technological capabilities through proprietary solutions, partnerships or acquisition.

For more Exela news, commentary, and industry perspectives, visit: https://investors.exelatech.com/

And please follow us on social:

Twitter: https://twitter.com/exelatech  

LinkedIn: https://www.linkedin.com/company/exela-technologies  

Facebook: https://www.facebook.com/exelatechnologies/  

Instagram: https://www.instagram.com/exelatechnologies  

The information posted on the Company’s website and/or via its social media accounts may be deemed material to investors. Accordingly, investors, media and others interested in the Company should monitor the Company’s website and its social media accounts in addition to the Company’s press releases, SEC filings and public conference calls and webcasts.

About Exela Technologies

Exela Technologies is a business process automation (BPA) leader, leveraging a global footprint and proprietary technology to provide digital transformation solutions enhancing quality, productivity, and end-user experience. With decades of experience operating mission-critical processes, Exela serves a growing roster of more than 4,000 customers throughout 50 countries, including over 60% of the Fortune® 100. Utilizing foundational technologies spanning information management, workflow automation, and integrated communications, Exela’s software and services include multi-industry, departmental solution suites addressing finance and accounting, human capital management, and legal management, as well as industry-specific solutions for banking, healthcare, insurance, and the public sector. Through cloud-enabled platforms, built on a configurable stack of automation modules, and over 17,500 employees operating in 23 countries, Exela rapidly deploys integrated technology and operations as an end-to-end digital journey partner.

Investor and/or Media Contacts:
Vincent Kondaveeti
E: vincent.kondaveeti@exelatech.com
T: 929-620-1849

Mary Beth Benjamin
E: IR@exelatech.com
T:  646-277-1216

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.